Mitä tietoja lapsidiateksesta? Tässä artikkelissa ilmaistaan prevalenssi % / 1000. Täytyy tarkistaa.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178689/
Ensin jotain yleistä ja Koreasta:
GLOBAL TREND IN DIABETES AND IGT
The
International Diabetes Federation provides comprehensive estimates of
the absolute numbers and prevalence of diabetes and IGT globally [21].
The total global prevalence of diabetes and IGT in 2010 was estimated
at 6.6% and 7.9%, respectively, and is expected to rise to 7.8% and
8.4%, respectively, in 2030 (Table 4).
It is estimated that 285 million and 344 million people worldwide will
have diabetes and IGT, respectively, in 2010.
By 2030, the number of
people with diabetes and IGT is projected to increase to 438 million and
472 million, respectively, of the adult population.
The largest
increases will take place in the regions dominated by developing
economies, such as Southeast Asia and the West Pacific region. The
prevalence of diabetes and IGT among Korean adults aged 20 to 79 years
in 2010 was estimated at 9.0% and 9.4%, respectively, and is expected to
rise to 11.4% and 11.5%, respectively, in 2030.
The number of Korean
people with diabetes and IGT was 3.3 million and 3.4 million,
respectively, in 2010, and is expected to increase to 4.3 million and
4.4 million, respectively, in 2030.
SITAATTI: Late-Breaking Pediatric Endocrinology III (posters)
Endocrine Society's 98th Annual Meeting and Expo, April 1–4, 2016 - Boston
Prevalence of Diabetes Among Children and Adolescents from 2002 to 2013 in Korea
Presentation Number: LBSun-02
Date of Presentation:
April 3, 2016
Abstract:Introduction
The prevalence of childhood obesity and its comorbidities including diabetes are increasing in worldwide. Despite importance and social concern of diabetes in childhood, there are limited data and reports. The aim of the study is to analyze the changes in the prevalence of diabetes in Korean youth by sex and age.
Methods
The estimated percentages and the total number of people less than 25 years with diabetes were determined using the information from the National Health Information Database from January 2002 through to December 2013 made by National Health Insurance Service (NHIS). Diagnosis of diabetes was based on the disease-classification codes from the health insurance claim forms and database on Health Screening Service. Type of diabetes was defined based on KCD code (type 1 diabetes E10, type 2 diabetes E11, unspecified E12-E14). Case, prevalence (per 1,000) and trend of diabetes were estimated by year, sex and age group in youth aged 0 to 24. Sex and age were adjusted by resident registration.
Results
In 2002,
41,693 of
17,116,776 youth were visited physician with diabetes
and the prevalence was 2.44 per 1000.
In 2013, 69,727 of 14,258,851 youth were visited physician with diabetes
and the prevalence was 4.89 per 1000.
The prevalence of type 1 diabetes was 0.52 per 1000
and type 2 diabetes was 1.23 per 1000
and other types of diabetes 0.68 per 1000 in 2002.
The prevalence of type 1 diabetes was 0.52 per 1000 and type 2 diabetes was 2.89 per 1000 and other types of diabetes 1.48 per 1000 in 2013.
Between 2002 and 2013, the prevalence of diabetes in Korean youth was significantly increased 2.01 times however type 1 diabetes did not showed significant change (0.99). Type 2 diabetes (2.35) and unspecified types of diabetes (2.18) increased significantly.
In age group 5-9 years and 10-14 years showed remarkable increase in Type 2 diabetes 2.59, 2.54 fold respectively, although 20-24 years was the highest prevalence.
Conclusion
The prevalence of diabetes (except type 1 diabetes) among Korean children and adolescents has been increased between 2002 and 2013. Given its high prevalence of youth diabetes shown the further studies including trend analysis of other comorbidities and closed monitoring are required.
Nothing to Disclose: S. Chung, K. Lee.
The prevalence of childhood obesity and its comorbidities including diabetes are increasing in worldwide. Despite importance and social concern of diabetes in childhood, there are limited data and reports. The aim of the study is to analyze the changes in the prevalence of diabetes in Korean youth by sex and age.
Methods
The estimated percentages and the total number of people less than 25 years with diabetes were determined using the information from the National Health Information Database from January 2002 through to December 2013 made by National Health Insurance Service (NHIS). Diagnosis of diabetes was based on the disease-classification codes from the health insurance claim forms and database on Health Screening Service. Type of diabetes was defined based on KCD code (type 1 diabetes E10, type 2 diabetes E11, unspecified E12-E14). Case, prevalence (per 1,000) and trend of diabetes were estimated by year, sex and age group in youth aged 0 to 24. Sex and age were adjusted by resident registration.
Results
In 2002,
41,693 of
17,116,776 youth were visited physician with diabetes
and the prevalence was 2.44 per 1000.
In 2013, 69,727 of 14,258,851 youth were visited physician with diabetes
and the prevalence was 4.89 per 1000.
The prevalence of type 1 diabetes was 0.52 per 1000
and type 2 diabetes was 1.23 per 1000
and other types of diabetes 0.68 per 1000 in 2002.
The prevalence of type 1 diabetes was 0.52 per 1000 and type 2 diabetes was 2.89 per 1000 and other types of diabetes 1.48 per 1000 in 2013.
Between 2002 and 2013, the prevalence of diabetes in Korean youth was significantly increased 2.01 times however type 1 diabetes did not showed significant change (0.99). Type 2 diabetes (2.35) and unspecified types of diabetes (2.18) increased significantly.
In age group 5-9 years and 10-14 years showed remarkable increase in Type 2 diabetes 2.59, 2.54 fold respectively, although 20-24 years was the highest prevalence.
Conclusion
The prevalence of diabetes (except type 1 diabetes) among Korean children and adolescents has been increased between 2002 and 2013. Given its high prevalence of youth diabetes shown the further studies including trend analysis of other comorbidities and closed monitoring are required.
Nothing to Disclose: S. Chung, K. Lee.
Inga kommentarer:
Skicka en kommentar